Loading...
The COVID-19 pandemic - a cause for late presentation of sarcoma patients?
Croxford, William Kirwadi, A. Kumar, A. Coyle, Catherine
Croxford, William
Kirwadi, A.
Kumar, A.
Coyle, Catherine
Citations
Altmetric:
Abstract
Background to the audit: The World Health organization (WHO) declared
COVID-19 a global pandemic in March 2020, with subsequent lockdown in
the UK and social distancing. There was a subsequent perception of more
advanced patient presentation at our regional sarcoma multidisciplinary
team meeting (MDTM) (Manchester and Oswestry Sarcoma Service
(GMOSS)). Audits of MDTMs were performed prior to and during the
pandemic to determine if this was the case.
Standard: Local standard was determined by the first audit of MDTMs in
2019. 21.2% presented with metastatic disease. 28.8% had palliative treatment recommendation.
Indicator:
1. Percentage of patients with metastatic disease.
2. Percentage of MDTM outcomes recommending palliative treatment.
Target: 1. 21%
2. 29%
Methodology: GMOSS database MDTM outcomes were obtained for six
MDTMs prior to the pandemic, JuneeNovember 2019, to identify a pre-pandemic standard, and then for six MDTMs during the pandemic,
JuneeNovember 2020. Benign/relisted patients were excluded. Malignant
cases were classed as metastatic or localised. Treatment intent was recorded
as radical or palliative.
Results of first audit round: 92 patients were discussed, 66 (71.7%) malignant cases. 14 (21.2%) had metastatic disease and 19 (28.8%) had palliative
treatment recommendation.
First action plan: Compare local pre-pandemic standard to 2020.
Results of second audit round: 79 patients discussed, 58 (73.4%) malignant
cases. 24 (41.4%) had metastatic disease and 27 (46.5%) had palliative treatment recommendation. Rates of metastatic disease and palliative treatment
are higher during the pandemic.
Second action plan: Patients are presenting later during the pandemic. For
discussion at Greater Manchester cancer pathway board to raise awareness
and consider input to primary care and patient education/support. Re-audit
required in one to two years.
Affiliation
Description
Date
2022
Publisher
Collections
Files
Keywords
Type
Meetings and Proceedings
Citation
Croxford W, Kirwadi A, Kumar A, Coyle C. The COVID-19 Pandemic – A Cause for Late Presentation of Sarcoma Patients?. Vol. 34, Clinical Oncology. Elsevier BV; 2022. p. e3.